• Latest
    • AI
    • Careers
    • Copyright
    • Community & Inclusion
    • Events Videos
    • Law firm news
    • Trade secrets
    • INTA 2026
  • In-house
  • Trademarks
  • Patents
  • Jurisdictions
    • Europe
    • Americas
    • Asia
    • Australasia
    • Africa
    • Unified Patent Court
  • Rankings
    • About Rankings
    • Practice Area Rankings
    • Global In-House Elite 2026
    • Influential Women in IP 2026
    • Leaders 2026
    • Directory
  • WIPR Insights
    • Magazines
    • IP services: Product walk-throughs
    • Whitepapers
    • Webinars
  • Events
    • Events schedule
  • About
  • Contact
  • Newsletter
  • Login
  • Subscribe
  • Home
  • About
  • Contact
  • Newsletter
  • Login


Request Trial
  • Home
  • Copyright
  • India: Patents-in-waiting
shutterstock_1215378886_-ilovephoto_ka
23 September 2019CopyrightJoginder Singh

India: Patents-in-waiting

Patenting can sometimes be time-consuming. As of today, the Indian patent office, (IPO), can take three to four years to grant a patent under the regular examination process, so what can an applicant do when a competitor starts copying an invention before the grant of a patent, ie, while a patent application for the same invention is pending with IPO for disposal?

Already registered?

Login to your account


If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
Section 3(d) strikes again in GSK India patent defeat
2 August 2013   India’s Intellectual Property Appeal Board has revoked a patent covering GlaxoSmithKline’s breast cancer drug Tykerb, in the latest blow to western pharmaceutical companies in India.
Patents
A revolution: biotech patents in India
1 January 2011   It has taken a long time for India to develop a productive environment for biotechnology. But recent developments look to have put it on the right track. Archana Shanker explains.


Editor's picks

Where have all the trademarks gone?: How word scarcity is a growing headache for brands
Trademarks
Where have all the trademarks gone?: How word scarcity is a growing headache for brands
11 September 2026

Editor's picks

Trademarks
Where have all the trademarks gone?: How word scarcity is a growing headache for brands
11 September 2026
Patents
Belgium arrest over semiconductor espionage claims raises stakes over key tech
9 September 2026
Copyright
More papers target AI as tech, politics, and publishers draw battle lines
7 September 2026
Trademarks
India clears way to grapple with long-pending trademark cases
7 September 2026
Patents
Clarivate’s IP president: ‘We have a head start in creating AI agents’
4 September 2026
Patents
InterDigital’s Josh Schmidt: Disney’s streaming ‘workaround’ won’t work
1 September 2026

More articles

Where have all the trademarks gone?: How word scarcity is a growing headache for brands
Munger, Tolles & Olson enlists ex-Paul Hastings trial litigator
Via Licensing’s new data centre patent pool opens for business
Playback: Lessons from Philips v Bansal
Surviving the new AI prosecution gauntlet
Patent prosecution made simpler, faster, and more efficient
IP in Russia: Facts, fiction and strategic guidance
Behind the numbers: China’s next phase of IP demand

  • Home
  • News
  • Directory
  • About us
  • Contact
  • Privacy Policy
  • Terms of Use
  • Terms of Subscription

WIPR
Newton Media Ltd
Kingfisher House
21-23 Elmfield Road
BR1 1LT
United Kingdom

  • Twitter
  • Linkedin